Schering-Plough Corp.

2000 Galloping Hill Road,
Kenilworth, New Jersey 07033
United States,
(908) 298-4000

Schering-Plough Corp. is a manufacturer and sells pharmaceuticals.

M&A Summary

Buy vs Sell

Year ≤ '02 '03 '04 '05 '06 '07 T
Buy (0.4/yr) # 3 - - 1 - 1 5
vol $85M $12.4B $12.5B
Sell (0.0/yr) # 1 - - - - - 1

Top M&A Advisors

Financial Deals
Join to Access.
Legal Deals
Join to Access.

Deal Values

> $1B Sign-up to View
$100M to $1B Sign-up to View
< $100M Sign-up to View
TOTAL Sign-up to View
Largest Organon BioSciences N.V.
$12.4B (2007-11-19)
Sell # Total
> $1B Sign-up to View
$100M to $1B Sign-up to View
< $100M Sign-up to View
Total Sign-up to View

Schering-Plough was acquired by Merck on November 03, 2009.

Schering-Plough has acquired 5 companies of its own. It has also divested 1 asset.

Schering-Plough’s largest acquisition to date was in 2007, when it acquired Organon BioSciences N.V. for $12.4B. Schering-Plough has acquired in 4 different US states, and 2 countries. The Company’s most targeted sectors include life science (80%) and apparel/textiles (20%).

When analyzing the life science sector as a whole, according to Mergr, in the last 3 years, there are 411 life science companies that have made at least 1 acquisition, 15 have acquired at least 5 companies, and 2 have acquired more than 10 companies. The most prolific strategic life science acquirer over the past 3 years is Eurofins Scientific SA, with 29 acquisitions. The most prolific private equity acquirer in the life science sector over the past 3 years is Ampersand Capital Partners with 5 platform acquisitions.

Join Mergr and gain access to Schering-Plough’s M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the life science sector.

What's Mergr?

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
  • 3.4K Private Equity Firms
  • 120K M&A Transactions
  • 129K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 2.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 35K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.